Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders ; volume:84 ; number:11 ; day:4 ; month:10 ; year:2024 ; pages:1365-1378 ; date:11.2024
Drugs ; 84, Heft 11 (4.10.2024), 1365-1378, 11.2024
- Creator
-
Carpi, Matteo
Mercuri, Nicola Biagio
Liguori, Claudio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-024-02096-3
- URN
-
urn:nbn:de:101:1-2502132105094.297646390068
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carpi, Matteo
- Mercuri, Nicola Biagio
- Liguori, Claudio
- SpringerLink (Online service)
Other Objects (12)
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Alzheimer’s disease prevention: from risk factors to early intervention
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Alzheimer’s disease prevention: from risk factors to early intervention
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease
Alzheimer’s disease prevention: from risk factors to early intervention
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold